Veroniek E M Harbers (Veroniek Harbers)

Years Active: 2021-2023
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Veroniek E M Harbers, Lilly G J M Zwerink, Gerard A Rongen, Willemijn M Klein, Carine J M van der Vleuten, Ingrid M P van Rijnsoever, Lynda Gerdsen-Drury, Uta E Flucke, Bas H Verhoeven, Peter C J de Laat, Chantal M A M van der Horst, Leo J Schultze Kool, D Maroeska W M Te Loo
Clinical differences in sirolimus treatment with low target levels between children and adults with vascular malformations - A nationwide trial. Clinical and translational science (2023)
D Maroeska W M Te Loo, Veroniek E M Harbers, Lars Vermeltfoort, Marieke J H Coenen
Influence of genetic variants on the pharmacokinetics and pharmacodynamics of sirolimus: a systematic review. Pharmacogenomics (2023)
Veroniek E M Harbers, Nathalie van der Salm, Sjoert A H Pegge, Carine J M van der Vleuten, Bas H Verhoeven, Sabine L A G Vrancken, Leo J Schultze Kool, Joris Fuijkschot, D Maroeska M W M Te Loo
Effective low-dose sirolimus regimen for kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon in young infants. British journal of clinical pharmacology 88 (6) (2022)
Veroniek E M Harbers, Gerard A P J M Rongen, Carine J M van der Vleuten, Bas H Verhoeven, Peter C J de Laat, Chantal M A M van der Horst, Willemijn M Klein, Leo J Schultze Kool, D Maroeska W M Te Loo
Patients with Congenital Low-Flow Vascular Malformation Treated with Low Dose Sirolimus. Advances in therapy 38 (6) (2021)

Veroniek E M Harbers.css-eqlu8i{font-size:small;padding-left:4px;} (Veroniek Harbers)